Cross‐company collaboration to leverage analytics for clinical quality and accelerate drug development: The IMPALA industry group

• Egile Nagusiak: Timothé Ménard (Egilea), Kyle Young (Egilea), Laura Siegel (Egilea), Jennifer Emerson (Egilea), Robert Studt (Egilea), Leslie Sidor (Egilea), The IMPALA Industry Group (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2021-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Quality functions from pharmaceutical sponsor companies aim to increase the use of analytics in their oversight of Good Clinical Practices and Pharmacovigilance activities. To leverage and accelerate progress, several companies decided to establish a collaborative model. The goals of this collaborat...